Latest News about HOTH
Recent news which mentions HOTH
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 04, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 04, 2022
From Benzinga
Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
January 04, 2022
Tickers
HOTH
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
From Benzinga
Hoth Therapeutics Announces Submission of Orphan Designation Application for HT-KIT to Treat Mastocytosis
December 21, 2021
Tickers
HOTH
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 20, 2021
From Benzinga
Hoth Therapeutics Reports Finishing Up a Busy Year of Research Across its Portfolio of Drug Candidates
December 20, 2021
Tickers
HOTH
From Benzinga
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 01, 2021
From Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
November 30, 2021
Tickers
HOTH
From Benzinga
Hoth Inks Research Agreement With North Carolina State University For Study of Preclinical Candidate To Treat Mast Cell Cancers
November 16, 2021
Tickers
HOTH
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 16, 2021
From Benzinga
Hoth Therapeutics Enters Into Agreements with WuXi STA; Attempts to Get New Cancer Treatment Closer to Clinical Trials
November 11, 2021
Tickers
HOTH
From Benzinga
This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria
November 09, 2021
From Benzinga
Clinical-Stage Biopharmaceutical Company HOTH Says It Is on a Mission to Develop Next-Generation Therapeutics to Meet Patient Needs
November 03, 2021
From Benzinga
Hoth Therapeutics Says the Possibilities Could Be Endless
October 28, 2021
Tickers
HOTH
From Benzinga
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans
October 12, 2021
Tickers
HOTH
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 08, 2021
From Benzinga
EXCLUSIVE: Hoth Reports Safety Data From Early-Stage Study Of BioLexa Platform In Eczema
September 08, 2021
Tickers
HOTH
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.